|
| 100 Years of Alzheimer Research
Paul S. Aisen, MD |
|
| Altered sleep patterns in Alzheimer’s Disease
Sonia Ancoli-Israel, Ph.D.; Professor of Psychiatry UCSD |
|
Primary prevention of dementia – review of current trials, methodological issues and perspectives
Sandrine Andrieu, MD, PhD
|
|
Molecular Imaging in Early Detection of Alzheimer’s Disease
Jorge R. Barrio, Ph.D.
|
|
|
Novel Optical Biological Control Tools: Towards Enabling Integrative Analysis of Neural Systems
Ed Boyden, PhD |
|
|
Diabetes-A Strong Risk Factor for Cognitive Dysfunction and Alzheimer’s Disease
Pamela Maher, The Salk Institute |
|
|
Genetic Moderators of the Relationship of Obstructive Sleep Apnea to the Development of Alzheimer’s Disease
Ruth O’Hara |
|
|
Drugs for Alzheimer’s Disease: Is the single-target approach going to work?
David Schubert, The Salk Institute |
|
|
Biomarkers for AD Clinical trials
Gabriel Vargas |
|
|
Biomarkers for monitoring the progression of Alzheimer’s disease in clinical trials: the Alzheimer’s Disease Neuroimaging Initiative
Michael W. Weiner, P. Aisen, R. Petersen, C. Jack, W. Jagust, J. Trojanowski, L. Shaw, A. Toga, L. Beckett, A. Gamst |
|
|
New Technologies to Assess Cognition at Home
Jeffrey Kaye, MD , Oregon Center for Aging & Technology, Oregon Health & Sciences University
|
|
|
The amyloid hypothesis
Checler Frédéric
|
|
|
Unraveling the Mysteries of Dementia with Lewy Bodies and Associated Disorders: The Monaco, Nice, Montreal (MNM)
Initiative.
Oury Monchi
|
|
|
Advances in Biomarkers and Modeling for the Development of Improved Therapeutics: Early Alzheimer’s Treatment
Eric Siemers, MD
|
|
|
C-jun N-terminal Kinase Regulates the First Events Of
Synaptic Dysfunction in Alzheimer’s disease
Alessandra Sclip
|
|
|
Synthetic Amyloid-β Oligomers Impair Long-Term Memory Independently of Cellular Prion Protein
Claudia Balducci
|
|
|
Actual Challenges of Alzheimer Dementia Approach. An Overview.
Luiza Spiru
|
|
|
Progranulin Plasma Levels as Potential Biomarker for the Identification of GRN Deletion Carriers. A Case with Atypical Onset as Clinical Mild Cognitive Impairment Converted to Alzheimer’s Disease
Daniela Galimberti, PhD
|
|
|
Denaturing high performance liquid chromatography (dHPLC) screening to find out genetic polymorphisms in the sirtuin gene family relevant for Alzheimer’s disease susceptibility
Diego Albani, PhD
|
|
|
|
|
